The company has definitely pivoted and seems to be leaving S/C in the rear view mirror...I posted right after the CD12 results that they should cancel any more s/c trial efforts and jus focus on Long Haulers Cancer and HIV to preserve cash . Got a bit ripped for that one but it looks like I was on the right track. they needed to preserve cash and go for the diseases which have long term effects.